Scannell Timothy J 4
4 · NovoCure Ltd · Filed Jun 6, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Scannell Timothy J
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-04+16,697→ 16,697 totalExercise: $16.72From: 2026-06-04Exp: 2035-06-04→ Ordinary Shares (16,697 underlying) - Award
Ordinary Shares
2025-06-04+11,215→ 17,233 total
Footnotes (2)
- [F1]Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders.
- [F2]Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders.